Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
2,813,216
-
Shares change
-
+81,800
-
Total reported value, excl. options
-
$65,682,880
-
Value change
-
+$2,051,866
-
Number of buys
-
29
-
Number of sells
-
-28
-
Price
-
$23.35
Significant Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q1 2019
64 filings reported holding PGHY - INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH as of Q1 2019.
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,813,216 shares
.
Largest 10 shareholders include Invesco Ltd. (461,443 shares), Maxim Capital Management LLC (354,332 shares), AlphaStar Capital Management, LLC (215,269 shares), MORGAN STANLEY (182,280 shares), Eqis Capital Management, Inc. (156,273 shares), BOSTON ADVISORS LLC (132,771 shares), CABOT WEALTH MANAGEMENT INC (116,692 shares), LINCOLN NATIONAL CORP (107,436 shares), Sowell Financial Services LLC (99,723 shares), and BANK OF AMERICA CORP /DE/ (88,619 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.